Hanover, MD (July 12, 2021) — Major, Lindsey & Africa (MLA), the world’s leading legal search firm, today announced the placement of Brendan St. Amant as vice president, head of legal at Synlogic, Inc. in Cambridge, Mass. The search was conducted by Amy Katz, managing director and Robert Mannino, director, both in MLA’s In-House Counsel Recruiting group in Boston.
Brendan will lead Synlogic’s legal function; work cross-functionally with internal stakeholders; collaborate closely with the legal, business and executive teams; and have broad oversight responsibilities, including corporate transactional, contract management, corporate governance, SEC, and compliance/regulatory matters.
Synlogic is a publicly traded clinical-stage biopharmaceutical company that is bringing the transformative potential of synthetic biology to medicine. With a premier synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic medicines that target validated underlying biology to treat disease in new ways. Synlogic’s proprietary pipeline includes Synthetic Biotics for the treatment of metabolic disorders, including Phenylketonuria (PKU) and Enteric Hyperoxaluria (HOX). The company is also building a portfolio of partner-able assets in immunology and oncology.
“It was a true pleasure to partner with Synlogic on this significant search. Not only is Brendan an outstanding and experienced biotech attorney, but his energy, passion and commitment to finding transformative new medicines for patients will be a perfect fit for Synlogic,” said Amy Katz. “We are excited to hear about Brendan’s accomplishments and contributions at Synlogic and are eager to follow Synlogic’s anticipated success over the coming months and years,” added Bob Mannino.Brendan most recently served as vice president, Legal at Ohana Biosciences, Inc., a clinical-stage, commercializing company, advising the board of directors, executives and colleagues across a variety of complex business, legal and compliance matters. Prior to Ohana, he spent several years with Vertex Pharmaceuticals Inc., a global biotechnology company creating transformative medicines for people with serious and life-threatening diseases, as director and senior counsel. Before going in-house, Brendan was a partner with Donnelly, Conroy & Gelhaar, LLP in their Complex Commercial Litigation and Government Enforcement practices and an associate with Goodwin Procter LLP. He began his legal career clerking for The Hon. Alvin W. Thompson, Chief, U.S. District Court in Hartford, Connecticut. Brendan earned his J.D. from Harvard Law School, his M.P.P. from Harvard Kennedy School of Government, and his B.A. from Cornell.
For media inquiries please contact us at: